These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 5722496)
21. [Supidimide, a non-teratogenic thalidomide analog for the treatment of leprosy reaction?]. Sheskin J; Mückter H; Frankus E Hautarzt; 1983 Apr; 34(4):168-70. PubMed ID: 6853166 [No Abstract] [Full Text] [Related]
22. [Leprous reaction and thalidomide. Results of treatment of 30 cases]. Saul A Prensa Med Mex; 1969; 34(11):403-9. PubMed ID: 5381704 [No Abstract] [Full Text] [Related]
23. Thalidomide in leprosy therapy. Mohr W Int J Lepr Other Mycobact Dis; 1971; 39(2):598-9. PubMed ID: 4948096 [No Abstract] [Full Text] [Related]
24. The effects of thalidomide on leprosy reaction. Languillon J Int J Lepr Other Mycobact Dis; 1971; 39(2):590-2. PubMed ID: 4948094 [No Abstract] [Full Text] [Related]
25. Thalidomide in dermatology and leprosy. Lancet; 1985 Jul; 2(8446):80-1. PubMed ID: 2861530 [No Abstract] [Full Text] [Related]
26. Supplies of thalidomide for use in leprosy. Loretti A; Barchi E Lepr Rev; 1986 Mar; 57(1):76-7. PubMed ID: 3702585 [No Abstract] [Full Text] [Related]
27. An internally-controlled double blind trial of thalidomide in severe erythema nodosum leprosum. Waters MF Lepr Rev; 1971 Mar; 42(1):26-42. PubMed ID: 4338720 [No Abstract] [Full Text] [Related]
29. [Motor-conduction velocity of cubital nerves in patients with leprosy reactions. Summary of a 13-year observation series during thalidomide therapy]. Sheskin J; Yaar I Hautarzt; 1979 Jul; 30(7):376-9. PubMed ID: 478858 [TBL] [Abstract][Full Text] [Related]
30. [Our experience in the therapy of leprous reactions with thalidomide]. Baccaredda-Boy A; Bertamino R Minerva Dermatol; 1968 Aug; 43(8):357-9. PubMed ID: 5745776 [No Abstract] [Full Text] [Related]
31. Use of thalidomide in leprosy. Crawford CL Adverse Drug React Toxicol Rev; 1994; 13(4):177-92. PubMed ID: 7734638 [No Abstract] [Full Text] [Related]
32. An open trial with clofazimine in the management of recurrent lepra reaction using thalidomide as a control drug. Iyer CG; Ramu G Lepr India; 1976 Oct; 48(4 Suppl):690-4. PubMed ID: 1026805 [No Abstract] [Full Text] [Related]
33. Thalidomide in lepra reaction (ENL) in lepromatous leprosy patients. Chandorkar AG; Burte NP; Jadhav JH; Gade RK; Bulakh PM; Tayshete SN; Kale VM Indian J Lepr; 1984; 56(2):264-8. PubMed ID: 6548496 [TBL] [Abstract][Full Text] [Related]
34. Supplies of thalidomide for use in leprosy. Neelamkavil P Lepr Rev; 1986 Sep; 57(3):273. PubMed ID: 3784762 [No Abstract] [Full Text] [Related]
35. Five years' experience with thalidomide treatment in leprosy reaction. Sheskin J; Sagher F Int J Lepr Other Mycobact Dis; 1971; 39(2):585-8. PubMed ID: 4948092 [No Abstract] [Full Text] [Related]
36. Thalidomide enhances defective monocyte function in lepromatous leprosy. Nielsen H; Bennike T Lancet; 1984 Jul; 2(8394):98-9. PubMed ID: 6146029 [No Abstract] [Full Text] [Related]
37. [Hansen L: action of thalidomide on a severe outburst]. Duperrat B; Puissant A; Goudie ; David V; Saurat JM Bull Soc Fr Dermatol Syphiligr; 1971; 78(3):291-2. PubMed ID: 5134979 [No Abstract] [Full Text] [Related]
38. Thalidomide induces imbalances in T-lymphocyte sub-populations in the circulating blood of healthy males. Gad SM; Shannon EJ; Krotoski WA; Hastings RC Lepr Rev; 1985 Mar; 56(1):35-9. PubMed ID: 3872986 [No Abstract] [Full Text] [Related]
39. Recent experience with thalidomide in Hansen's Disease. Sheskin J Int J Dermatol; 1970; 9(1):56-8. PubMed ID: 4912951 [No Abstract] [Full Text] [Related]
40. The treatment of lepra reaction in lepromatous leprosy. Fifteen years' experience with thalidomide. Sheskin J Int J Dermatol; 1980; 19(6):318-22. PubMed ID: 7005131 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]